companies

acceXible

Founded 2018
Employees 3+
Primary contact
Barcelona Tech City, Plaça de Pau Vila, 1
Bloc A, Planta 3, Porta 3A1
08003 Barcelona
Spain
+34 649332295
Links
https://accexible.com/
Sections
Technologies
Founded by a multidisciplinary team, AcceXible is a startup developing a speech analysis platform based on AI models to early detect diseases such as dementia, Parkinson's and coronary disease, among others. The company's solution enables a rapid, digital, cost-effective tool to diagnose and monitor diseases — reducing the burden on the healthcare system and the caregivers, and allowing them to better respond to the needs of individuals. AcceXible's solution could also be used in a clinical trial, offering a quantitative criterion to screen and measure the evolution of the participants during the clinical trial.
Select partners: QuirónSalud, Neotec/CDTI, Enisa, BEAZ, Masschallenge, AENOR - Joven Empresa Innovadora, Grupo SPRI Taldea.
Founded 2018
Employees 3+
Primary contact
Barcelona Tech City, Plaça de Pau Vila, 1
Bloc A, Planta 3, Porta 3A1
08003 Barcelona
Spain
+34 649332295
Links
https://accexible.com/
Sections
Technologies

Funding 💰

Total €1.3M
Select investors Center for Industrial Technological Development, Enisa, Crowdcube

Key people 🧑‍🤝‍🧑

Highlights ⭐

  • Solving the real need: In Europe, only 20% of people with dementia are diagnosed at an early stage. The AcceXible model allows early and non-invasive diagnosis and the possibility of monitoring the evolution of the disease remotely.
  • Solid founding team: The CEO has extensive experience in bringing R&D projects to the market and has been named Entrepreneur of the Year in 2020 by the Spanish prestigious elreferente ranking. The CFO, on the other hand, has 20-year experience in the financial world.
  • Solution for different purposes: acceXible's technology could be used by clinicians as a screening tool, by health instance companies and providers for detecting and monitoring mild cognitive impairment and dementia, for telemedicing for remote detection and monitoring, and in clinical trials to provide a quantitative criterion to screen participants.
  • Expansion plans: The company plans to expand to France, the United Kingdom and the United States, among other markets.

Video ▶️

Awards & Recognitions 🏆

  • 2022 LG NOVA Mission for the Future challenge: Among the 50 selected startups 🔗
  • 2021 Healthy Ageing Innovation Award 🔗
  • 2020 Expansión Startup Awards: First Prize 🔗
Last update: August 17, 2022